Syndax Posts Impressive Financial Results for Q3 2025
November 4, 2025 - 04:24
Syndax has reported robust financial results for the third quarter of 2025, showcasing significant growth and strong market demand for its products. The company achieved total revenue of $45.9 million, marking a 21% increase compared to the previous quarter. This growth was primarily driven by Revuforj® (revumenib), which generated net revenue of $32.0 million. Notably, prescriptions for Revuforj surged by 25% over the second quarter, indicating a rising interest and demand for the treatment.
Additionally, Niktimvo™ (axatilimab-csfr) contributed $45.8 million in net revenue, reported by Incyte, alongside $13.9 million in collaboration revenue for Syndax. A significant milestone was reached on October 24, 2025, when Revuforj received FDA approval for the treatment of relapsed/refractory NPM1m acute myeloid leukemia, further enhancing its market position.
With a strong financial foundation, Syndax holds $456.1 million in cash, cash equivalents, and investments, positioning the company well for future growth and development.
MORE NEWS
July 10, 2026 - 06:15
Gov. Kelly Ayotte signs tax credit to incentivize businesses to invest in employee childcareNew Hampshire Governor Kelly Ayotte held a ceremonial bill signing on Thursday to promote a recently enacted tax credit designed to encourage businesses to invest in childcare for their workers....
July 9, 2026 - 18:31
Topaz vs. Evoque: New head-to-head study for TTVR devices now underwayA new clinical study is now underway to directly compare two leading transcatheter tricuspid valve replacement (TTVR) systems. The trial will pit the redesigned Topaz device from TRiCares against...
July 9, 2026 - 02:11
West Orange School Business Administrator on Paid Leave After $13.5M DeficitThe West Orange school district has placed its business administrator on paid administrative leave after the discovery of a $13.5 million budget deficit, according to documents released to...
July 8, 2026 - 04:18
State Establishes NC Economic Forecasting Initiative at UNC Kenan-Flagler Business SchoolThe North Carolina General Assembly has set aside $3 million to create the North Carolina Economic Forecasting Initiative, or NCEFI. The money, drawn from the state budget for the 2026-27 fiscal...